Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Holdsworth-Carson SJ, Dior UP, Colgrave EM, Healey M, Montgomery GW, Rogers PAW, et al
.png)
503A compounding is subject to state pharmacy board oversight and USP sterility standards for injectable preparations, but it is not subject to the FDA's drug approval process, pre-market review, or post-market surveillance requirements that apply to branded pharmaceutical products
Contraindications: Lidocaine Injection is contraindicated in patients with a known hypersensitivity to lidocaine or any component of the formulation
Experiencing dizziness along with blurred vision can be alarming and disruptive
Charlson et al., 1992
US$ 27.68
US$ 21.88
US$ 28.19
